Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease - Wikidata - awgldk - TriplyDB

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

http://www.wikidata.org/entity/Q34589414

about

SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques.Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers Role of Hybrid Brain Imaging in Neuropsychiatric Disorders Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers.Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals Brain imaging in Alzheimer disease Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected Harmonized diagnostic criteria for Alzheimer's disease: recommendations Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease Brain PET in the diagnosis of Alzheimer's disease Development of positron emission tomography β-amyloid plaque imaging agents Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniques Clinical profile of PiB-positive corticobasal syndrome Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia Neurological imaging: statistics behind the pictures APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers PET amyloid-beta imaging in preclinical Alzheimer's disease Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease.Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.Amyloid imaging in dementias with atypical presentation.Auditory spatial processing in Alzheimer's disease.Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia Disruption of functional connectivity in clinically normal older adults harboring amyloid burden.Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain Current neuroimaging techniques in Alzheimer's disease and applications in animal models Imaging frontotemporal lobar degeneration.Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.

P2860

Q21144971-BDC56575-C00C-4A4A-B5F6-76762D35CE92 Q22001055-D2FC4B3F-6CA5-4FB3-9D1B-ECAE327C268D Q24594531-7C9F0833-EC1C-410E-8E3C-64F7DFA81BBE Q26745508-7CFDD27D-33BC-4A47-A134-9AE42DBE06EB Q26768454-9F1A2E2A-341C-46A1-80C1-AAF6909264D6 Q26830740-156681BE-328D-45E7-923A-62BB77D6BE9A Q26995259-7DE23C87-5627-4649-8FA9-7B9B35E535BF Q26995405-B21D7ED5-CB2E-427D-92F7-20ED17925F8F Q26996299-03B354A5-72C6-444B-9000-FB35A57B1434 Q27007436-11FAB5D8-CBED-4164-906E-5DD162ECDFBA Q27009157-5A1C959C-F903-4EF7-A93D-DFF317F6E6E8 Q27009411-1E405A7D-0022-4FDB-98C8-B2FD73B18A76 Q27011549-5D94D6C3-10D0-47C5-BBE2-564E42C5B656 Q27012742-753384AE-5E4D-4019-9539-E8B9B490FACE Q27303745-D1E31FB9-C9BD-43B4-A7FD-631D1FF5BF6A Q28088506-558F9D15-1BC1-40EB-9C7C-251638102E2E Q28395854-10CF4991-0FEA-4A18-940F-83FF9E38CEE4 Q28486042-AA9FBEAE-800C-4653-80A6-03C55959189A Q28705235-0F516DF7-E333-481C-99AE-9E5658E54B5A Q28741434-35A588FE-4080-4834-94F4-98BFF8682989 Q29416986-647BF209-7D0E-47DB-89DE-6EDA14E1D584 Q29614407-77729AC7-4296-4426-AC40-7DCA2E1B7CB6 Q29620245-AC252CC9-23C6-4FE3-8A10-79809BADACD3 Q30040695-FB87B3CB-BF03-45F2-ACB3-7E5451BA749A Q30100986-7E099DF2-06CA-489C-A3E6-7D999BB80FEB Q30361851-905523F3-3AED-4353-9974-B61EECA51EA2 Q30413572-B9B82578-EDD1-4F95-A8C2-069C27913E0F Q30417342-4ACB91E1-5280-438E-8D88-465696E24EC2 Q30418044-71779B51-1DF8-41B7-8050-CCFDD857C8AC Q30422060-E4C85DCD-A033-45F4-8424-643EA2C5B5A6 Q30426091-FC0FE9CF-1AEA-4A8A-AD90-DDCEB63DC11A Q30436083-B68E1B7D-7D4D-40B0-8CAB-B7922D34B964 Q30436728-482C9663-4BEE-4F5F-98A8-E44115B3AFE3 Q30486197-E2236CDE-987E-4378-A2B2-79BFFB210FF3 Q30492809-C4B908C8-D327-4857-89BB-B40697DDFE0E Q30497749-98304882-4FF8-487C-A888-5A8D439129E2 Q30542245-6C73AF62-F05C-41AB-BF5B-F40067DB2DF5 Q30576714-D517ABE6-82A9-46FB-839F-E08C764A6BE1 Q30846573-06448858-EA01-4A23-9734-B2F2FA6388A8 Q30945416-72C483FE-2CD3-4EB0-8C99-3D05F3C7473D

P2860

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

http://www.wikidata.org/entity/Q34589414

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Post-mortem correlates of in v ...... al case of Alzheimer's disease

@ast

Post-mortem correlates of in v ...... al case of Alzheimer's disease

@en

Post-mortem correlates of in v ...... al case of Alzheimer's disease

@nl

type

label

Post-mortem correlates of in v ...... al case of Alzheimer's disease

@ast

Post-mortem correlates of in v ...... al case of Alzheimer's disease

@en

Post-mortem correlates of in v ...... al case of Alzheimer's disease

@nl

prefLabel

Post-mortem correlates of in v ...... al case of Alzheimer's disease

@ast

Post-mortem correlates of in v ...... al case of Alzheimer's disease

@en

Post-mortem correlates of in v ...... al case of Alzheimer's disease

@nl

P1433

Q34589414-16B535DB-2707-45F6-9536-445FB753BBD6

P1476

Q34589414-FF5803CB-FB86-4EB2-BA07-F054E124A84D

P2093

Q34589414-2C426ACC-8725-4767-BC97-EAD0B961264E

Q34589414-31599AF1-A99D-4E55-98EA-E5E4CB4B38BD

Q34589414-36D423AF-F339-48A5-B5AC-2BE54F23D4B1

Q34589414-5585E11E-CBF1-4FC6-965A-D09EE8047548

Q34589414-5B51CC3D-C1EF-4411-B218-D3EC1D3F448B

Q34589414-65F2E7B3-BDEF-426D-9F04-AF9132181201

Q34589414-68ADEB78-E07B-4530-AD50-5DC58CB843F0

Q34589414-8C30E204-CB1F-4B02-BB01-D80B1EA2310C

Q34589414-91DFF9F5-F345-492A-9A1B-A210C8E39234

Q34589414-9B9E4499-500C-4816-8C48-69AEC66196C1

P2860

Q34589414-00800071-E7AD-42C7-A5B1-C110699E8F84

Q34589414-01BE85F2-3FD8-4B71-8997-DC288397B503

Q34589414-07529CA5-9D12-433B-983A-6F8B4FA1AF20

Q34589414-0AC6749F-E655-4BC5-AE93-46389692028D

Q34589414-0C33E2EF-50B2-4720-80DE-4472948A4BB3

Q34589414-0C763BD0-2193-45A9-9332-EDF091E243FC

Q34589414-118A6326-928C-49B5-A2E2-3B7E724F8E1D

Q34589414-1D5A961C-C9A3-4D49-8C6F-C88E4BCAD5E6

Q34589414-1E30511F-F694-4DF4-8787-292675DDEB57

Q34589414-2CABF64E-EFE4-4D3F-BFB9-41BE7E0C4143

P304

Q34589414-20A6D56E-5C3E-45C1-941C-524ACE9E267A

P31

Q34589414-42B5E31C-AA11-46E9-A152-BB6F13344290

P356

Q34589414-506A588C-D472-4808-8F39-5B381BEB43B2

P407

Q34589414-9A810B61-10B8-4477-A0B4-C49419AFBE3E

P433

Q34589414-695F649B-CEBD-4938-86BC-EE17EB0E1939

P478

Q34589414-85733F28-13E3-4FDF-B953-70B6444191D6

P50

Q34589414-41EDB65D-512C-4101-98D5-3C8936FCEBCE

P577

Q34589414-8605F62E-B11D-437F-B1DC-E516A4FAE465

P5875

Q34589414-36DFEB51-2E5B-4139-A324-5C58FF57FC62

P698

Q34589414-E001FC2C-ED8F-4092-B19F-93847DCB81EC

P921

Q34589414-2C181018-CA51-4342-99A3-D4659B0AFCBC

Q34589414-C244D9C0-FC36-45DA-8750-4387FDCC0360

P932

Q34589414-B3B00247-CCC9-4876-BEA5-3A6FC3D60F24

P356

P1433

P1476

Post-mortem correlates of in v ...... al case of Alzheimer's disease

@en

P2093

Barbara A Isanski

http://www.w3.org/2001/XMLSchema#string

Brian J Lopresti

http://www.w3.org/2001/XMLSchema#string

Caroline E Hope

http://www.w3.org/2001/XMLSchema#string

Chester A Mathis

http://www.w3.org/2001/XMLSchema#string

Eric E Abrahamson

http://www.w3.org/2001/XMLSchema#string

Julie C Price

http://www.w3.org/2001/XMLSchema#string

Manik L Debnath

http://www.w3.org/2001/XMLSchema#string

Milos D Ikonomovic

http://www.w3.org/2001/XMLSchema#string

Nicholas D Tsopelas

http://www.w3.org/2001/XMLSchema#string

Ronald L Hamilton

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Biomarkers of Alzheimer disease.

The role of biomarkers in clinical trials for Alzheimer disease

Diagnosis of Alzheimer's disease in a community hospital-based brain bank program.

P304

1630-1645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWN016

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 6

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

William E. Klunk

P577

2008-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5511985

http://www.w3.org/2001/XMLSchema#string

P698

18339640

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

amyloid imaging

P932

2408940

http://www.w3.org/2001/XMLSchema#string